Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation

Juris J. Liepnieks, Merrill D. Benson

Research output: Contribution to journalArticlepeer-review

80 Scopus citations


It has been hypothesized that transthyretin (TTR) amyloidosis may progress after orthotopic liver transplantation (OLT) as a result of continued amyloid fibril synthesis and deposition from normal TTR. To test this hypothesis amyloid fibrils were isolated from cardiac tissues of three patients who died 1 1/2 to 5 1/2 years after OLT: two with Val30Met and one with Thr60Ala TTR. The ratio of variant to normal TTR in each case was determined and compared with the ratio of variant to normal in cardiac tissues from seven patients who died with TTR amyloidosis but who had not had liver transplantation. Tissues from patients with TTR amyloidosis without OLT included three with Val30Met, two with Thr60Ala, one with ΔVal122, and one with Val122Ile. All tissues from patients without OLT had greater amounts of variant TTR than normal TTR except for the Val122Ile in which the ratio was 50:50. The overall median variant to normal ratio was 60:40 with a range of 50-70% variant. In contrast, the mean percentage of variant TTR in the three tissues from patients after OLT was 25% (range 20-35). These data are consistent with the continued deposition of normal TTR in cardiac tissue after liver transplantation.

Original languageEnglish (US)
Pages (from-to)277-282
Number of pages6
Issue number4
StatePublished - Nov 7 2007


  • Amyloidosis
  • Cardiomyopathy
  • Liver transplantation
  • Transthyretin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation'. Together they form a unique fingerprint.

Cite this